Multidrug-Resistant Salmonella Serotype Typhimurium – United States, 1996

A multidrug-resistant strain of Salmonella serotype Typhimurium known as Definitive Type 104 (DT104) has emerged as an increasing case of Salmonella infections in the United Kingdom (UK). DT104 isolates in the UK are highly resistant to antimicrobial agents, frequently demonstrating a pattern of res...

Full description

Saved in:
Bibliographic Details
Published in:MMWR. Morbidity and mortality weekly report 1997-04, Vol.46 (14), p.308-310
Main Author: Centers for Disease Control and Prevention (CDC)
Format: Article
Language:English
Subjects:
Antimicrobial agents
Bacteria
Bacterial diseases
Child
Children
Disease Outbreaks
Disease Reservoirs
Drug resistance
Drug Resistance, Microbial
Drug Resistance, Multiple
Epidemiology
Foodborne illnesses
Fungal diseases
Fungal infections
Humans
Infections
Infectious diseases
Nebraska - epidemiology
Salmonella
Salmonella Infections - drug therapy
Salmonella Infections - epidemiology
Salmonella Infections - microbiology
Salmonella typhimurium
Salmonella typhimurium - classification
Salmonella typhimurium - drug effects
Salmonellosis
Schools
Serotyping
Statistics
United States - epidemiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A multidrug-resistant strain of Salmonella serotype Typhimurium known as Definitive Type 104 (DT104) has emerged as an increasing case of Salmonella infections in the United Kingdom (UK). DT104 isolates in the UK are highly resistant to antimicrobial agents, frequently demonstrating a pattern of resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (R-type ACSSuT). This report summarizes surveillance data documenting the rapid emergence of DT104 R-type ACSSuT in the United States and preliminary findings from the investigation of the first outbreak of DT104 infections in this country.
ISSN:0149-2195
1545-861X